Skip to main content

Table 3 Between drug effect on RV volumetric parameters showing a significant difference in RV ESV and RVEF favouring deferiprone.

From: Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

 

Treatment effect

 
 

Deferiprone-Deferoxamine

 
 

Mean

95% CI

p

EDV

-1.21

-4.44

2.03

0.47

ESV

-1.82

-3.27

-0.37

0.014

SV

0.64

-2.02

3.31

0.64

EF

1.16

0.30

2.01

0.008